首页 | 本学科首页   官方微博 | 高级检索  
检索        


Elevated Plasma S100B,Psychotic Symptoms,and Cognition in Schizophrenia
Authors:Huiqiong Deng  Ramandeep S Kahlon  Satyajit Mohite  Pooja A Amin  Giovana Zunta-Soares  Gabriela D Colpo  Laura Stertz  Gabriel R Fries  Consuelo Walss-Bass  Jair C Soares  Olaoluwa O Okusaga
Institution:1.Harris County Psychiatric Center,University of Texas Health Science Center at Houston,Houston,USA;2.Department of Psychiatry and Behavioral Sciences,McGovern Medical School at the University of Texas Health Science Center at Houston,Houston,USA;3.Menninger Department of Psychiatry and Behavioral Sciences,Baylor College of Medicine,Houston,USA
Abstract:S100B is a calcium binding protein mainly produced by glial cells. Previous studies have shown elevated levels of S100B in patients with schizophrenia. We measured S100B levels in fasting plasma of 39 patients with schizophrenia and 19 adult healthy controls. We used linear regression to compare S100B between patients and controls. In patients only, we also investigated the relationship between S100B levels and psychotic symptoms (assessed by the Positive and Negative Syndrome Scale), and cognitive function (assessed by the NIH Toolbox Cognition Battery), respectively by calculating Pearson’s correlation coefficients. Mean plasma S100B was significantly higher in the patient group than in the control group. There were no significant correlations between plasma S100B and psychotic symptoms or cognition.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号